All Stories

  1. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Bo Abrahamsen, Professor Marianne Andersen

  2. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome

    Article • February 2015, Bioscientifica

    Professor Marianne Andersen, Bo Abrahamsen

  3. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes

    Article • Acta Obstetricia Et Gynecologica Scandinavica, December 2014, Wiley

    Professor Marianne Andersen

  4. A rare cause of Cushing's syndrome: an ACTH-secreting phaeochromocytoma

    Article • BMJ Case Reports, October 2014, BMJ

    Professor Marianne Andersen

  5. Body Composition Is Improved During 12 Months' Treatment With Metformin Alone or Combined With Oral Contraceptives Compared With Treatment With Oral Contraceptives in Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2014, Endocrine Society

    Professor Marianne Andersen

  6. Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome

    Article • Journal of Endocrinological Investigation, June 2014, Springer Science + Business Media

    Professor Marianne Andersen

  7. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome

    Article • Human Reproduction, June 2014, Oxford University Press (OUP)

    Professor Marianne Andersen

  8. Changes in body composition following 12 months randomized treatment with metformin vs oral contraceptives vs combined treatment in polycystic ovary syndrome

    Article • April 2014

    Professor Marianne Andersen

  9. Pregnancy in women with polycystic ovary syndrome is associated with higher risk of gestational diabetes mellitus, but not of other adverse obstetric outcomes

    Article • April 2014

    Professor Marianne Andersen

  10. MANAGEMENT OF ENDOCRINE DISEASE: GH excess: diagnosis and medical therapy

    Article • October 2013, Bioscientifica

    Professor Marianne Andersen

  11. Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)

    Article • PLoS ONE, September 2013, PLOS

    Professor Marianne Andersen

  12. Bone mineral density and vitamin D in PCOS and hirsutism

    Article • Expert Review of Endocrinology & Metabolism, September 2013, Taylor & Francis

    Professor Marianne Andersen

  13. Supportive relationships – Psychological effects of group counselling in women with polycystic ovary syndrome (PCOS)

    Article • Communication & Medicine, May 2013, Equinox Publishing

    Professor Marianne Andersen

  14. Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973–1991

    Article • Fertility and Sterility, March 2013, Elsevier

    Professor Marianne Andersen

  15. Androgen levels and sexual activity in young men ( n =773), 20--29 years of age, a population based study. Odense Androgen Study

    Article • March 2013

    Professor Marianne Andersen

  16. Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men

    Article • March 2013

    Professor Marianne Andersen

  17. Effects of exercise and group counselling on body composition and VO2maxin overweight women with polycystic ovary syndrome

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 2013, Wiley

    Professor Marianne Andersen

  18. Clinical Manifest X-Linked Recessive Adrenoleukodystrophy in a Female

    Article • Case Reports in Neurological Medicine, January 2013, Hindawi Publishing Corporation

    Professor Marianne Andersen

  19. The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism

    Article • Acta Obstetricia Et Gynecologica Scandinavica, August 2012, Wiley

    Professor Marianne Andersen

  20. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, July 2012, Elsevier

    Professor Marianne Andersen

  21. Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome

    Article • Fertility and Sterility, November 2011, Elsevier

    Professor Marianne Andersen

  22. F417 GROUP COUNSELLING AND PHYSICAL ACTIVITY OF PATIENTS WITH POLYCYSTIC OVARIAL SYNDROME (PCOS)

    Article • European Journal of Pain Supplements, September 2011, Wiley

    Professor Marianne Andersen

  23. Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome

    Article • Gynecological Endocrinology, July 2011, Taylor & Francis

    Professor Marianne Andersen

  24. Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark

    Article • Clinical Endocrinology, November 2010, Wiley

    Professor Marianne Andersen

  25. Risk of impaired glucose tolerance in normal weight hirsute women during four years observation

    Article • Acta Obstetricia Et Gynecologica Scandinavica, August 2010, Wiley

    Professor Marianne Andersen

  26. Thiazolinedione treatment in PCOS – an update

    Article • Gynecological Endocrinology, June 2010, Taylor & Francis

    Professor Marianne Andersen

  27. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

    Article • Gynecological Endocrinology, February 2010, Taylor & Francis

    Professor Marianne Andersen

  28. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment

    Article • Clinical Endocrinology, November 2009, Wiley

    Professor Marianne Andersen

  29. A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome

    Article • Fertility and Sterility, March 2009, Elsevier

    Professor Marianne Andersen

  30. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

    Article • Gynecological Endocrinology, January 2009, Taylor & Francis

    Professor Marianne Andersen

  31. Association of Pioglitazone Treatment with Decreased Bone Mineral Density in Obese Premenopausal Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2008, Endocrine Society

    Professor Marianne Andersen

  32. A 12‐month randomized crossover study on the effects of Lanreotide Autogel and Octreotide long‐acting repeatable on GH and IGF‐l in patients with acromegaly

    Article • Clinical Endocrinology, September 2007, Wiley

    Professor Marianne Andersen

  33. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome

    Article • Clinical Endocrinology, September 2007, Wiley

    Professor Marianne Andersen, Professor Timothy Charles Skinner

  34. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome

    Article • Fertility and Sterility, August 2006, Elsevier

    Professor Marianne Andersen, Professor Timothy Charles Skinner

  35. Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2005, Endocrine Society

    Professor Marianne Andersen

  36. Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism

    Article • Clinical Endocrinology, June 2005, Wiley

    Professor Marianne Andersen

  37. Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

    Article • Fertility and Sterility, December 2004, Elsevier

    Professor Marianne Andersen, Professor Timothy Charles Skinner